Nuyttens Louise, Heyerick Marah, Roes Maxime, Moens Elise, Van Dender Céline, Wallaeys Charlotte, Hochepied Tino, Timmermans Steven, Vandewalle Jolien, Libert Claude
Center for Inflammation Research, Vlaams Instituut Voor Biotechnologie (VIB), Ghent, Belgium.
Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Front Immunol. 2025 Oct 8;16:1652516. doi: 10.3389/fimmu.2025.1652516. eCollection 2025.
Tumor necrosis factor (TNF) causes a lethal systemic inflammatory response syndrome (SIRS) which is characterized by significant metabolic alterations. Based on liver RNA sequencing, we found that TNF impairs the malate-aspartate shuttle (MAS), an essential redox shuttle that transfers reducing equivalents across the inner mitochondrial membrane thereby recycling cytosolic NAD. This downregulation of MAS genes in TNF-induced SIRS likely results from loss of HNF4α function, which appears to be the key transcription factor involved. Using Slc25a13 mice lacking citrin - a crucial MAS component - we demonstrate that MAS dysfunction exacerbates TNF-induced metabolic dysregulations and lethality. Disruptive NAD regeneration leads to diminished mitochondrial β-oxidation, leading to elevated levels of circulating free fatty acids (FFAs) and to hepatic lipid accumulation. Simultaneously, MAS dysfunction promotes glycolysis coupled to lactate production and reduces lactate-mediated gluconeogenesis, culminating in severe hyperlactatemia that triggers VEGF-induced vascular leakage. Overall, MAS dysfunction contributes to metabolic failure and lethality in TNF-induced SIRS, highlighting its potential as a promising, therapeutic target.
肿瘤坏死因子(TNF)会引发致命的全身炎症反应综合征(SIRS),其特征为显著的代谢改变。基于肝脏RNA测序,我们发现TNF会损害苹果酸-天冬氨酸穿梭(MAS),这是一种重要的氧化还原穿梭机制,可将还原当量转运穿过线粒体内膜,从而循环利用胞质中的NAD。TNF诱导的SIRS中MAS基因的这种下调可能是由于HNF4α功能丧失所致,HNF4α似乎是关键的参与转录因子。使用缺乏柠檬酸转运蛋白(一种关键的MAS成分)的Slc25a13小鼠,我们证明MAS功能障碍会加剧TNF诱导的代谢失调和致死率。破坏性的NAD再生导致线粒体β-氧化减少,导致循环游离脂肪酸(FFA)水平升高和肝脏脂质积累。同时,MAS功能障碍促进糖酵解并与乳酸生成相关联,并减少乳酸介导的糖异生,最终导致严重的高乳酸血症,引发VEGF诱导的血管渗漏。总体而言,MAS功能障碍导致TNF诱导的SIRS中的代谢衰竭和致死率,突出了其作为有前景的治疗靶点的潜力。